The In Vivo vs. Ex Vivo Debate: Strategic Decisions Shaping the...

adicionou um novo artigo Health

2025-11-19 12:17:11 -

The In Vivo vs. Ex Vivo Debate: Strategic Decisions Shaping the Delivery and Commercialization of Gene-Edited Therapies.

One of the central technical challenges in the commercialization of gene editing is the delivery of the editing tools to the target cells. This issue has segmented the clinical development pathway into two primary methods: *Ex Vivo* and *In Vivo*. The *Ex Vivo* approach involves extracting a patient's cells (such as T-cells for cancer or stem cells for blood disorders), genetically modifying...

0 Comentários 0 Compartilhamentos 275 Visualizações 0 Anterior